Safi Bio-manufactured human blood
1 known investors
Safi Biotherapeutics manufactures adult stem-cell derived human red blood cells (mRBCs) as a cell therapy blood transfusion product, aiming to produce them at industrial scale for civilian and military transfusion needs. Its work targets both chronic transfusion indications, such as sickle cell disease, and acute settings including hospitals and battlefields.